|
US7763609B2
(en)
|
2003-12-15 |
2010-07-27 |
Schering Corporation |
Heterocyclic aspartyl protease inhibitors
|
|
KR101052122B1
(ko)
|
2005-10-25 |
2011-07-26 |
시오노기세야쿠 가부시키가이샤 |
아미노디히드로티아진 유도체
|
|
EP2147914B1
(en)
|
2007-04-24 |
2014-06-04 |
Shionogi&Co., Ltd. |
Aminodihydrothiazine derivatives substituted with cyclic groups
|
|
EP2151435A4
(en)
|
2007-04-24 |
2011-09-14 |
Shionogi & Co |
PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF ALZHEIMER'S DISEASE
|
|
US20100317850A1
(en)
|
2008-01-18 |
2010-12-16 |
Yuichi Suzuki |
Condensed aminodihydrothiazine derivative
|
|
MX2010013256A
(es)
*
|
2008-06-13 |
2010-12-21 |
Shionogi & Co |
Derivado heterociclico que contiene azufre que tiene actividad inhibitoria de beta-secretasa.
|
|
AU2009277485B2
(en)
*
|
2008-07-28 |
2013-05-02 |
Eisai R&D Management Co., Ltd. |
Spiroaminodihydrothiazine derivatives
|
|
JP5666304B2
(ja)
*
|
2008-09-30 |
2015-02-12 |
エーザイ・アール・アンド・ディー・マネジメント株式会社 |
新規な縮合アミノジヒドロチアジン誘導体
|
|
JPWO2010047372A1
(ja)
*
|
2008-10-22 |
2012-03-22 |
塩野義製薬株式会社 |
Ｂａｃｅ１阻害活性を有する２−アミノピリミジン−４−オンおよび２−アミノピリジン誘導体
|
|
GB0912777D0
(en)
|
2009-07-22 |
2009-08-26 |
Eisai London Res Lab Ltd |
Fused aminodihydropyrimidone derivatives
|
|
GB0912778D0
(en)
|
2009-07-22 |
2009-08-26 |
Eisai London Res Lab Ltd |
Fused aminodihydro-oxazine derivatives
|
|
WO2011044185A2
(en)
|
2009-10-08 |
2011-04-14 |
Schering Corporation |
Pentafluorosulfur imino heterocyclic compounds as bace-1 inhibitors, compositions, and their use
|
|
WO2011044187A1
(en)
|
2009-10-08 |
2011-04-14 |
Schering Corporation |
Iminothiadiazine dioxide compounds as bace inhibitors, compositions, and their use
|
|
WO2011044184A1
(en)
|
2009-10-08 |
2011-04-14 |
Schering Corporation |
Pentafluorosulfur imino heterocyclic compounds as bace-1 inhibitors, compositions, and their use
|
|
UA108363C2
(uk)
|
2009-10-08 |
2015-04-27 |
|
Похідні імінотіадіазиндіоксиду як інгібітори bace, композиція на їх основі і їх застосування
|
|
JPWO2011071109A1
(ja)
*
|
2009-12-11 |
2013-04-22 |
塩野義製薬株式会社 |
アミノ基を有する縮合ヘテロ環化合物
|
|
JPWO2011071135A1
(ja)
|
2009-12-11 |
2013-04-22 |
塩野義製薬株式会社 |
オキサジン誘導体
|
|
EA021240B1
(ru)
|
2010-06-09 |
2015-05-29 |
Янссен Фармацевтика Нв |
Производные 5,6-дигидро-2h-[1,4]оксазин-3-иламина в качестве ингибиторов бета-секретазы (bace)
|
|
CA2816285A1
(en)
|
2010-10-29 |
2012-05-03 |
Shionogi & Co., Ltd. |
Naphthyridine derivative
|
|
EP2634188A4
(en)
|
2010-10-29 |
2014-05-07 |
Shionogi & Co |
FUSIONED AMINODIHYDROPYRIMIDINE DERIVATIVE
|
|
US9840507B2
(en)
|
2010-12-22 |
2017-12-12 |
Janssen Pharmaceutica, Nv |
5,6-dihydro-imidazo[1,2-a]pyrazin-8-ylamine derivatives useful as inhibitors of beta-secretase (BACE)
|
|
GB201100181D0
(en)
*
|
2011-01-06 |
2011-02-23 |
Eisai Ltd |
Fused aminodihydrothiazine derivatives
|
|
GB201101140D0
(en)
|
2011-01-21 |
2011-03-09 |
Eisai Ltd |
Fused aminodihydrothiazine derivatives
|
|
SG191710A1
(en)
*
|
2011-01-21 |
2013-08-30 |
Eisai R&D Man Co Ltd |
Methods and compounds useful in the synthesis of fused aminodihydrothiazine derivatives
|
|
GB201101139D0
(en)
|
2011-01-21 |
2011-03-09 |
Eisai Ltd |
Fused aminodihydrothiazine derivatives
|
|
MX340031B
(es)
|
2011-03-09 |
2016-06-21 |
Janssen Pharmaceutica Nv |
Derivados de 3,4-dihidropirrolo[1,2-a]pirazin-1-ilamina utiles como inhibidores de beta-secretasa (bace).
|
|
US9221839B2
(en)
|
2011-04-07 |
2015-12-29 |
Merck Sharp & Dohme Corp. |
C5-C6 oxacyclic-fused thiadiazine dioxide compounds as BACE inhibitors, compositions, and their use
|
|
US9145426B2
(en)
|
2011-04-07 |
2015-09-29 |
Merck Sharp & Dohme Corp. |
Pyrrolidine-fused thiadiazine dioxide compounds as BACE inhibitors, compositions, and their use
|
|
TW201247635A
(en)
|
2011-04-26 |
2012-12-01 |
Shionogi & Co |
Oxazine derivatives and a pharmaceutical composition for inhibiting BAC1 containing them
|
|
TW201302763A
(zh)
|
2011-05-24 |
2013-01-16 |
必治妥美雅史谷比公司 |
用於減少β－類澱粉產生之化合物
|
|
US8604024B2
(en)
|
2011-05-24 |
2013-12-10 |
Bristol-Myers Squibb Company |
Compounds for the reduction of beta-amyloid production
|
|
US8927535B2
(en)
*
|
2011-07-06 |
2015-01-06 |
Hoffman-La Roche Inc. |
Cyclopropyl-fused-1,3-thiazepines as BACE1 and/or BACE2 inhibitors
|
|
EP2747769B1
(en)
|
2011-08-22 |
2017-08-02 |
Merck Sharp & Dohme Corp. |
2-spiro-substituted iminothiazines and their mono-and dioxides as bace inhibitors, compositions and their use
|
|
EP2751116B1
(en)
|
2011-08-31 |
2016-10-12 |
Pfizer Inc |
Hexahydropyrano [3,4-d][1,3]thiazin-2-amine compounds
|
|
JO3143B1
(ar)
|
2012-04-03 |
2017-09-20 |
Lilly Co Eli |
مركبات تتراهيدرو بيرولو ثيازين
|
|
HUE030534T2
(hu)
|
2012-04-27 |
2017-05-29 |
Eisai R&D Man Co Ltd |
Eljárás 5-(difluormetil)pirazin-2-karbonsav elõállítására és elõállítási intermediere
|
|
ES2585262T3
(es)
|
2012-05-04 |
2016-10-04 |
Pfizer Inc |
Compuestos heterocíclicos de hexahidropiran[3,4-d][1,3]tiazin-2-amina sustituidos como inhibidores de PPA, BACE1 y BACE2
|
|
GB201212871D0
(en)
|
2012-07-20 |
2012-09-05 |
Eisai Ltd |
Novel compounds
|
|
JP2015529239A
(ja)
|
2012-09-20 |
2015-10-05 |
ファイザー・インク |
アルキル置換ヘキサヒドロピラノ［３，４−ｄ］［１，３］チアジン−２−アミン化合物
|
|
JP2016501827A
(ja)
|
2012-10-24 |
2016-01-21 |
塩野義製薬株式会社 |
Ｂａｃｅ１阻害作用を有するジヒドロオキサジンまたはオキサゼピン誘導体
|
|
PT2912041T
(pt)
*
|
2012-10-26 |
2017-02-13 |
Lilly Co Eli |
Inibidores de bace
|
|
CA2893256A1
(en)
|
2012-12-11 |
2014-06-19 |
Pfizer Inc. |
Hexahydropyrano [3,4-d][1,3]thiazin-2-amine compounds as inhibitors of bace1
|
|
WO2014098831A1
(en)
|
2012-12-19 |
2014-06-26 |
Bristol-Myers Squibb Company |
4,6-diarylaminothiazines as bace1 inhibitors and their use for the reduction of beta-amyloid production
|
|
EP2935282A1
(en)
|
2012-12-19 |
2015-10-28 |
Pfizer Inc. |
CARBOCYCLIC- AND HETEROCYCLIC-SUBSTITUTED HEXAHYDROPYRANO[3,4-d][1,3]THIAZIN-2-AMINE COMPOUNDS
|
|
US9309263B2
(en)
|
2013-01-29 |
2016-04-12 |
Amgen Inc. |
Fused multi-cyclic sulfone compounds as inhibitors of beta-secretase and methods of use thereof
|
|
CA2899938C
(en)
|
2013-02-12 |
2021-10-19 |
Buck Institute For Research On Aging |
Hydantoins that modulate bace-mediated app processing
|
|
JP2016507551A
(ja)
|
2013-02-13 |
2016-03-10 |
ファイザー・インク |
ヘテロアリール置換ヘキサヒドロピラノ［３，４−ｄ］［１，３］チアジン−２−アミン化合物
|
|
US9233981B1
(en)
|
2013-02-15 |
2016-01-12 |
Pfizer Inc. |
Substituted phenyl hexahydropyrano[3,4-d][1,3]thiazin-2-amine compounds
|
|
CA2902212C
(en)
*
|
2013-03-01 |
2020-10-13 |
Amgen Inc. |
Perfluorinated 5,6-dihydro-4h-1,3-oxazin-2-amine compounds as beta-secretase inhibitors and methods of use
|
|
KR20150124985A
(ko)
|
2013-03-08 |
2015-11-06 |
암젠 인크 |
베타-세크레타제 억제제로서 퍼플루오르화된 사이클로프로필 융합된 1,3-옥사진-2-아민 화합물 및 그의 사용 방법
|
|
TWI593692B
(zh)
|
2013-03-12 |
2017-08-01 |
美國禮來大藥廠 |
四氫吡咯并噻嗪化合物
|
|
MX368326B
(es)
|
2013-06-12 |
2019-09-27 |
Janssen Pharmaceutica Nv |
Derivados de 4-amino-6-fenil-5,6-dihidroimidazo[1,5-a]pirazin-3(2h )-ona como inhibidores de beta-secretasa (bace).
|
|
ES2721073T3
(es)
|
2013-06-12 |
2019-07-26 |
Janssen Pharmaceutica Nv |
Derivados de 4-amino-6-fenil-6,7-dihidro[1,2,3]triazolo[1,5 a]pirazina como inhibidores de beta-secretasa (BACE)
|
|
JO3318B1
(ar)
|
2013-06-18 |
2019-03-13 |
Lilly Co Eli |
مثبطات bace
|
|
US9096615B2
(en)
|
2013-07-30 |
2015-08-04 |
Amgen Inc. |
Bridged bicyclic amino thiazine dioxide compounds as inhibitors of beta-secretase and methods of use thereof
|
|
KR20180078347A
(ko)
|
2014-04-10 |
2018-07-09 |
화이자 인코포레이티드 |
2-아미노-6-메틸-4,4a,5,6-테트라히드로피라노[3,4-d][1,3]티아진-8a(8H)-일-1,3-티아졸-4-일 아미드
|
|
AU2015301028B2
(en)
|
2014-08-08 |
2019-09-26 |
Amgen Inc. |
Cyclopropyl fused thiazin-2-amine compounds as beta-secretase inhibitors and methods of use
|
|
JO3458B1
(ar)
|
2014-11-10 |
2020-07-05 |
H Lundbeck As |
2- أمينو-6- (دايفلوروميثيل) – 5، 5- ديفلورو-6-فينيل-3،4، 5، 6-تيتراهيدروبيريدين كمثبطات bace1
|
|
MA40941A
(fr)
|
2014-11-10 |
2017-09-19 |
H Lundbeck As |
2-amino-5,5-difluoro-6-(fluorométhyl)-6-phényl-3,4,5,6-tétrahydropyridines comme inhibiteurs de bace1
|
|
CR20170187A
(es)
|
2014-11-10 |
2018-02-01 |
H Lundbeck As |
2-Amino-3,5-difluoro-6-metil-6-fenil-3,4,5,6-tetrahidropiridinas en calidad de inhibidores de BACE1 para el tratamiento de la enfermedad de Alzheimer
|
|
AU2015367594C1
(en)
|
2014-12-18 |
2019-10-31 |
Janssen Pharmaceutica Nv |
2,3,4,5-tetrahydropyridin-6-amine and 3,4-dihydro-2H-pyrrol-5-amine compound inhibitors of beta-secretase
|
|
AR103680A1
(es)
|
2015-02-23 |
2017-05-24 |
Lilly Co Eli |
Inhibidores selectivos de bace1
|
|
CA2977667C
(en)
|
2015-03-19 |
2019-08-20 |
Eli Lilly And Company |
Aminothiazine compounds useful as selective bace1 inhibitors
|
|
AR104241A1
(es)
|
2015-04-29 |
2017-07-05 |
Lilly Co Eli |
Derivados de tetrahidrofuro tiazina como inhibidores de bace1 selectivos
|
|
US10246429B2
(en)
|
2015-08-06 |
2019-04-02 |
Amgen Inc. |
Vinyl fluoride cyclopropyl fused thiazin-2-amine compounds as beta-secretase inhibitors and methods of use
|
|
TW201717948A
(zh)
|
2015-08-10 |
2017-06-01 |
Ｈ 朗德貝克公司 |
包括給予２－胺基－３，５，５－三氟－３，４，５，６－四氫吡啶的聯合治療
|
|
CN107849056A
(zh)
*
|
2015-08-12 |
2018-03-27 |
H.隆德贝克有限公司 |
Bace1抑制剂2‑氨基‑7a‑苯基‑3,4,4a,5,7,7a‑六氢呋喃并[3,4‑b]吡啶
|
|
CA2993630A1
(en)
|
2015-08-12 |
2017-02-16 |
H. Lundbeck A/S |
2-amino-3-fluoro-3-(fluoromethyl)-6-methyl-6-phenyl-3,4,5,6-tetrahydropyridines as bace1 inhibitors
|
|
EP3353182A1
(en)
|
2015-09-24 |
2018-08-01 |
Pfizer Inc |
Tetrahydropyrano[3,4-d][1,3]oxazin derivatives and their use as bace inhibitors
|
|
JP2018531923A
(ja)
|
2015-09-24 |
2018-11-01 |
ファイザー・インク |
Ｎ−［２−（２−アミノ−６，６−二置換−４，４ａ，５，６−テトラヒドロピラノ［３，４−ｄ］［１，３］チアジン−８ａ（８Ｈ）−イル）−１，３−チアゾール−４−イル］アミド
|
|
JP2018534251A
(ja)
|
2015-09-24 |
2018-11-22 |
ファイザー・インク |
Ｂａｃｅ阻害剤として有用なｎ−［２−（３−アミノ−２，５−ジメチル−１，１−ジオキシド−５，６−ジヒドロ−２ｈ−１，２，４−チアジアジン−５−イル）−１，３−チアゾール−４−イル］アミド
|
|
TWI675034B
(zh)
*
|
2016-05-20 |
2019-10-21 |
美商美國禮來大藥廠 |
四氫呋喃并<img align="absmiddle" height="18px" width="27px" file="d10999.TIF" alt="其他非圖式 ed10999.png" img-content="tif" orientation="portrait" inline="yes" giffile="ed10999.png"></img>化合物及其作為選擇性ＢＡＣＥ１抑制劑之用途
|
|
WO2018083247A1
(en)
|
2016-11-04 |
2018-05-11 |
Janssen Pharmaceutica Nv |
4,4a,5,7-tetrahydro-3h-furo[3,4-b]pyridinyl compounds
|
|
AU2017376441B2
(en)
|
2016-12-15 |
2021-10-14 |
Amgen Inc. |
Oxazine derivatives as beta-secretase inhibitors and methods of use
|
|
US11021493B2
(en)
|
2016-12-15 |
2021-06-01 |
Amgen Inc. |
1,4-thiazine dioxide and 1,2,4-thiadiazine dioxide derivatives as beta-secretase inhibitors and methods of use
|
|
WO2018112086A1
(en)
|
2016-12-15 |
2018-06-21 |
Amgen Inc. |
Cyclopropyl fused thiazine derivatives as beta-secretase inhibitors and methods of use
|
|
AU2017376444B2
(en)
|
2016-12-15 |
2021-09-30 |
Amgen Inc. |
Thiazine derivatives as beta-secretase inhibitors and methods of use
|
|
MX394391B
(es)
|
2016-12-15 |
2025-03-24 |
Amgen Inc |
Derivados de tiazina y oxazina biciclicos como inhibidores de beta-secretasa y metodos de uso.
|
|
US20200010482A1
(en)
*
|
2017-03-07 |
2020-01-09 |
Janssen Pharmaceutica Nv |
Inhibitors of beta secretase
|
|
AU2018229722A1
(en)
*
|
2017-03-07 |
2019-08-08 |
Janssen Pharmaceutica Nv |
Inhibitors of beta secretase
|
|
WO2018162445A1
(en)
*
|
2017-03-07 |
2018-09-13 |
Janssen Pharmaceutica Nv |
Inhibitors of beta secretase
|
|
JP2020509064A
(ja)
*
|
2017-03-07 |
2020-03-26 |
ヤンセン ファーマシューティカ エヌ．ベー． |
βセクレターゼ阻害剤
|
|
WO2018162443A1
(en)
*
|
2017-03-07 |
2018-09-13 |
Janssen Pharmaceutica Nv |
Inhibitors of beta secretase
|
|
WO2018162444A1
(en)
*
|
2017-03-07 |
2018-09-13 |
Janssen Pharmaceutica Nv |
Inhibitors of beta secretase
|
|
CN110590517A
(zh)
*
|
2019-09-24 |
2019-12-20 |
武汉嘉诺康医药技术有限公司 |
一种3，4-二羟基-2′-氯苯乙酮的制备方法
|